Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Breast 1

Conditions

Sarcoma 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 95Specimen Handling 79Magnetic Resonance Spectroscopy 70Carboplatin 59Cisplatin 56Biopsy 56Nivolumab 51Radiotherapy 47Cyclophosphamide 44Paclitaxel 43Radiation 36durvalumab 33Gemcitabine 31olaparib 30Dexamethasone 30Etoposide 29Doxorubicin 28atezolizumab 26Taxes 25Rituximab 25Docetaxel 25Ipilimumab 24Bevacizumab 24Vincristine 23Lenalidomide 23Pemetrexed 22Cytarabine 22X-Rays 21Radiotherapy, Intensity-Modulated 21Prednisone 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Radiation Dose Hypofractionation × 90 days × Clear all
NCT03570827 2026-05-26

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Mayo Clinic

Phase 2 Completed
53 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT03274687 2026-05-20

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

NRG Oncology

Phase 3 Completed
296 enrolled 29 charts
Genitourinary

Prostate Adenocarcinoma

NCT03624478 2026-05-15

Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery

Mayo Clinic

Phase 2 Completed
25 enrolled 11 charts
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT03972930 2026-05-12

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

University of Wisconsin, Madison

Phase 2 Active not recruiting
48 enrolled 10 charts
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡